Providence Health Plan

1218 Massachusetts Ave
Cambridge, MA 02138

Cognito Therapeutics is at the forefront of innovative therapies designed to address Alzheimer's disease by targeting abnormal neuronal activity in the brain. Their non-invasive treatment method utilizes visual and auditory stimulation to evoke gamma wave activity, aiming to preserve cognitive function and brain structure in affected patients.

The company has garnered attention for its promising results from its Phase 2 OVERTURE trial, which demonstrated significant slowing of disease progression with no serious adverse events reported. With FDA Breakthrough Device Designation, Cognito Therapeutics is also exploring treatment options for other neurodegenerative diseases, expanding their impact in the field of neuromodulation.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesMassachusettsCambridgeProvidence Health Plan